| Oral contraceptive use in young women is associated with lower bone mineral density than that of controls. | |
| | |
MedLine Citation:
|
PMID: 15902418 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Osteoporosis is a skeletal disease affecting 44 million Americans. A primary strategy to prevent osteoporosis is to develop a high peak bone mass in youth. Oral contraceptives (OCs) alter hormones in women and could affect bone mass development. Fifty percent of American women between the ages of 20 and 24 years use OCs. However, the interaction between OCs and skeletal mineralization is poorly understood. Our aim was to compare bone mass [bone mineral density (BMD)] of young women who had a history of OC use, with regularly menstruating controls. We recruited 98 women who were 18 to 25 years of age and had a history of OC use (n=44, 3.4+/-1.9 years of OC use) and controls (n=58). BMD at the hip, whole-body, and spine [anterior-posterior (AP) and lateral grams per square centimeter] was measured by dual-energy X-ray absorptiometry (DXA). Physical activity [in metabolic equivalents (METs)] was measured via questionnaire, and grip strength was evaluated with an isometric dynamometer. Groups were similar in body mass index (BMI), fat mass, grip strength, calcium intake and physical activity, but OC users were slightly older than controls (21.3+/-1.9 years vs 20.3+/-1.6 years, P<0.05). In analysis of covariance, controlled for age and BMI, controls had significantly greater BMD than OC users at the AP and lateral spine, femoral neck, greater trochanter, total hip, and whole body (P<0.05). We conclude that, in this cross-sectional analysis, oral contraceptive use by young women may compromise bone health during a time when mineral is still accruing. |
| | |
Authors:
|
Hawley Almstedt Shoepe; Christine M Snow |
Related Documents
:
|
8829748 - Obstetric complications and schizophrenia: a meta-analysis. 8280828 - Case-control study of risk factors for cervical squamous-cell neoplasia in denmark. iii... 9554248 - Thromboembolic stroke in young women. a european case-control study on oral contracepti... 17917628 - Serum hdl-cholesterol in women using low dose oral contraceptives. 18489938 - Review of side-effect profile of combination ezetimibe and statin therapy in randomized... 21495808 - Vitamin d status of pregnant women in shanghai, china. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2005-05-19 |
Journal Detail:
|
Title: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Volume: 16 ISSN: 0937-941X ISO Abbreviation: - Publication Date: 2005 Dec |
Date Detail:
|
Created Date: 2005-12-19 Completed Date: 2006-03-30 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9100105 Medline TA: Osteoporos Int Country: England |
Other Details:
|
Languages: eng Pagination: 1538-44 Citation Subset: IM |
Affiliation:
|
Bone Research Laboratory, 13 Women's Building, College of Health and Human Sciences, Corvallis, Oregon 97331, USA. almstedh@onid.orst.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Absorptiometry, Photon
/
methods Adolescent Adult Bone Density / drug effects, physiology* Contraceptives, Oral / adverse effects* Cross-Sectional Studies Diet Estrogens / adverse effects Ethinyl Estradiol / adverse effects Exercise / physiology Female Hand Strength / physiology Hip Humans Progestins / adverse effects Spine |
| Chemical | |
Reg. No./Substance:
|
0/Contraceptives, Oral; 0/Estrogens; 0/Progestins; 57-63-6/Ethinyl Estradiol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Musculoskeletal manifestations of mild osteogenesis imperfecta in the adult.
Next Document: Toxicant-induced ER-stress and caspase activation in the olfactory mucosa.